Evidence map›Paper›PMID 30124623›Full record

ArticleThe journal of trauma and acute care surgery2018

Dynamic coagulability after injury: Is delaying venous thromboembolism chemoprophylaxis worth the wait?

Joshua J Sumislawski, Lucy Z Kornblith, Amanda S Conroy, Rachael A Callcut, Mitchell Jay Cohen

Registry-linked trialAbstract read
In one paragraph

Article in The journal of trauma and acute care surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07506473 (Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients), which is not on this map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07506473 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial

TypeinterventionalSponsorUniversity Hospital, GrenobleRan2026 to 2028Enrolled540ConditionsSevere Trauma Patient, Venous ThromboembolismArmsEnoxaparin standard dose, Enoxaparin intermediate dose
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Anatomic distribution and analysis of influencing factors on deep vein thrombosis in patients with spinal fractures caused by high-energy injuries.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pulmonary embolism following severe polytrauma: a retrospective study from a level I trauma center in China.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Trauma-induced pulmonary thromboembolism: What's update?Chinese journal of traumatology = Zhonghua chuang shang za zhi · 2022
    Review
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joshua J SumislawskiFrom the Department of Surgery, Denver Health Medical Center, University of Colorado, Denver, Colorado (J.J.S., M.J.C); Department of Surgery, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California (L.Z.K., A.S.C., R.A.C).
Lucy Z Kornblith
Amanda S Conroy
Rachael A Callcut
Mitchell Jay Cohen

Funding

Analysis and Characterization of Trauma-Induced CoagulopathyUM1HL120877 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MORRISSEY, JAMES H., WISNIEWSKI, STEPHEN R · 2013 to 2019
$26.6M
Post-Injury Platelet Biology: Mechanisms and OutcomesK23GM130892 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORNBLITH, LUCY ZUMWINKLE · 2018 to 2022
$995k
Advancing Outcome Metrics in Trauma Surgery Through Utilization of Big DataK01ES026834 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CALLCUT, RACHAEL A · 2015 to 2018
$889k
NHLBI NIH HHS UM1 HL120877NIEHS NIH HHS K01 ES026834NIGMS NIH HHS K23 GM130892
6 · The paper itself

Abstract

backgroundSeverely injured patients often progress from early hypocoagulable to normal and eventually hypercoagulable states, developing increased risk for venous thromboembolism (VTE). Prophylactic anticoagulation can decrease this risk, but its initiation is frequently delayed for extended periods due to concerns for bleeding. To facilitate timely introduction of VTE chemoprophylaxis, we characterized the transition from hypo- to hypercoagulability and hypothesized that trauma-induced coagulopathy resolves within 24 hours after injury.

methodsSerial blood samples were collected prospectively from critically injured patients for 120 hours after arrival at an urban Level I trauma center. Extrinsic thromboelastometry maximum clot firmness was used to classify patients as hypocoagulable (HYPO, <49 mm), normocoagulable (NORM, 49-71 mm), or hypercoagulable (HYPER, >71 mm) at each time point. Changes in coagulability over hospital course, VTE occurrence, and timing of prophylaxis initiation were analyzed.

results898 patients (median Injury Severity Score, 13; mortality, 12%; VTE, 8%) were enrolled. Upon arrival, 3% were HYPO (90% NORM, 7% HYPER), which increased to 9% at 6 hours before down-trending. Ninety-seven percent were NORM by 24 hours, and 53% were HYPER at 120 hours. Median maximum clot firmness began in the NORM range, up-trended gradually, and entered the HYPER range at 120 hours. Patients with traumatic brain injury (TBI) followed a similar course and were not more HYPO at any time point than those without TBI. Failure to initiate prophylaxis by 72 hours was predicted by TBI and associated with VTE development (27% vs 16%, p < 0.05).

conclusionsRegardless of injury pattern, trauma-induced coagulopathy largely resolves within 24 hours, after which hypercoagulability becomes increasingly more prevalent. Deferring initiation of chemoprophylaxis, which is often biased toward patients with intracranial injuries, is associated with VTE development. LEVEL OF EVIDENCE: Prognostic study, level III; Therapeutic, level IV.

Indexed as

AdultAnticoagulantsBlood CoagulationBlood Coagulation DisordersBrain Injuries, TraumaticChemopreventionFemaleHumansInjury Severity ScoreMaleMiddle AgedProspective StudiesThrombelastographyTime FactorsVenous ThromboembolismWounds and InjuriesAnticoagulants

Identifiers

PMID30124623
PMCPMC7326618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.